全球動物模型市場

到 2030 年，全球動物模型市場規模將達到 37 億美元

全球動物模型市場規模預計在2024年為24億美元，到2030年將達到37億美元，2024年至2030年的複合年成長率為7.4%。作為本報告分析的細分市場之一，小鼠市場預計將實現8.8%的複合年成長率，並在分析期結束時達到12億美元。大鼠市場在分析期間內的複合年成長率預計為7.5%。

美國市場規模估計為 6.546 億美元，中國市場預計複合年成長率為 11.8%

美國動物模型市場規模預計2024年達到6.546億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到7.883億美元，在2024-2030年的分析期內，複合年成長率為11.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.7%和7.2%。在歐洲，預計德國市場的複合年成長率為4.9%。

全球動物模型市場－主要趨勢與促進因素摘要

為什麼生物醫學研究對動物模型的需求越來越大？

生物醫學和製藥研究中對動物模型的日益依賴是市場成長的主要驅動力。隨著癌症、糖尿病和神經退化性疾病等慢性疾病的盛行率持續上升，對臨床前研究的需求也日益成長，以評估新療法的安全性和有效性。動物模型透過提供忠實模擬人類生理和病理的生物系統，在轉化研究中發揮至關重要的作用，使研究人員能夠深入了解疾病機制。對個人化醫療和基因治療的日益關注進一步加速了對能夠模擬特定人類遺傳條件的基因改造動物模型的需求。此外，FDA 和 EMA 等監管機構要求在核准人體測試的藥物之前使用動物模型進行臨床前研究，這進一步增強了動物模型在藥物開發平臺中的重要性。

科技進步如何影響動物模型市場？

基因工程和生物技術的創新正在徹底改變更精確、更可靠的動物研究模型的發展。 CRISPR-Cas9 基因編輯技術的開發使得創建高度特異性的基因改造動物模型成為可能，使研究人員能夠研究特定基因在疾病發展和進展中的作用。人工智慧 (AI) 與數據分析在動物研究中的融合也透過自動追蹤生理和行為反應提高了研究的精確度。此外，3D 生物列印和器官晶片技術的日益普及正在補充傳統的動物模型，增強了進行更精確、更符合倫理道德的研究的能力。這些技術進步不僅提高了臨床前研究的可重複性和可靠性，也為再生醫學和毒性測試開闢了新的可能性。

動物模型市場面臨哪些挑戰與機會？

動物模型市場面臨許多挑戰，包括倫理問題、監管審查以及替代檢測方法的可用性。圍繞動物研究使用的倫理爭議導致了更嚴格的指導方針訂定，動物福利組織的壓力也越來越大，促使該行業探索非動物替代品，例如試管內模型和電腦模擬。監管機構正在收緊動物福利合規要求，這進一步加劇了製藥和研究機構的市場格局。然而，這些挑戰也為市場相關人員提供了一個機會，可以開發更複雜、更人道的動物模型，最大限度地減少動物痛苦，同時最大限度地提高研究成果。人源化動物模型的應用日益廣泛，這種模型結合了人類細胞和基因，可以更好地複製人類病理，也為腫瘤學、免疫學和感染疾病研究開闢了新的途徑。

推動動物模型市場成長的關鍵因素有哪些？

動物模型市場的成長受到多種因素的推動，包括對新型療法的需求不斷成長、政府對生物醫學研究的資助不斷擴大、通用感染疾病的日益流行使得基於動物模型的研究成為必要。製藥公司正在大力投資臨床前研究以開發創新藥物和生技藥品，這推動了對能夠提供可靠的功效和安全性數據的先進動物模型的需求。人們對疫苗開發的日益關注，特別是鑑於新出現的感染疾病和全球健康威脅，進一步推動了市場的發展。此外，在獸醫研究中擴大使用動物模型來提高牲畜生產力和伴侶動物健康，這也促進了市場擴張。基因工程和分子生物學的不斷進步正在推動動物模型市場的持續成長，為全球研究機構和行業相關人員提供了新的機會。

部分

動物類型（小鼠、大鼠、豚鼠、倉鼠、其他動物類型）；用途（癌症、感染疾病、免疫疾病、其他）；最終用途（製藥/生物技術公司、受託研究機構、學術研究機構）

受訪公司範例

• Biocytogen Boston Corp.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• Cyagen US Inc.
• Genoway SA
• Hera Biolabs
• InnoSer Belgie NV
• Inotiv, Inc.
• Janvier Labs
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• The Jackson Laboratory

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Animal Model Market to Reach US$3.7 Billion by 2030

The global market for Animal Model estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Mice, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Rat segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$654.6 Million While China is Forecast to Grow at 11.8% CAGR

The Animal Model market in the U.S. is estimated at US$654.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$788.3 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Animal Model Market - Key Trends & Drivers Summarized

Why Is the Demand for Animal Models Rising in Biomedical Research?

The growing reliance on animal models in biomedical and pharmaceutical research is a key driver of market growth. As the prevalence of chronic diseases such as cancer, diabetes, and neurodegenerative disorders continues to rise, there is an increasing need for preclinical studies to evaluate the safety and efficacy of new therapeutics. Animal models play a crucial role in translational research by providing a biological system that closely mimics human physiology and pathology, allowing researchers to gain critical insights into disease mechanisms. The expanding focus on personalized medicine and gene therapy has further accelerated demand for genetically modified animal models that can simulate specific human genetic conditions. Additionally, regulatory bodies such as the FDA and EMA mandate preclinical testing using animal models before approving drugs for human trials, further cementing their importance in the drug development pipeline.

How Are Technological Advancements Shaping the Animal Model Market?

Innovations in genetic engineering and biotechnology are revolutionizing the development of more precise and reliable animal models for research applications. Advances in CRISPR-Cas9 gene-editing technology have enabled the creation of genetically modified animal models with high specificity, allowing researchers to study the role of specific genes in disease development and progression. The integration of artificial intelligence (AI) and data analytics in animal research is also improving study accuracy by enabling the automated tracking of physiological and behavioral responses. Furthermore, the increasing adoption of 3D bioprinting and organ-on-chip technologies is complementing traditional animal models, enhancing the ability to conduct more accurate and ethically responsible research. These technological advancements are not only improving the reproducibility and reliability of preclinical studies but are also opening up new opportunities in regenerative medicine and toxicology testing.

What Challenges and Opportunities Exist in the Animal Model Market?

The animal model market faces several challenges, including ethical concerns, regulatory scrutiny, and the availability of alternative testing methods. Ethical debates surrounding the use of animals in research have led to stringent guidelines and increased pressure from animal rights organizations, prompting the industry to explore non-animal alternatives such as in vitro models and computer simulations. Regulatory agencies are imposing stricter compliance requirements related to animal welfare, further complicating the market landscape for pharmaceutical and research institutions. However, these challenges present opportunities for market players to develop more refined and humane animal models that minimize suffering while maximizing research outcomes. The increasing adoption of humanized animal models, which incorporate human cells or genes to better replicate human conditions, is also opening new avenues for research in oncology, immunology, and infectious diseases.

What Are the Key Factors Driving Growth in the Animal Model Market?

The growth in the Animal Model market is driven by several factors, including the rising demand for novel therapeutics, expanding government funding for biomedical research, and the increasing prevalence of zoonotic diseases that require animal model-based studies. Pharmaceutical companies are investing heavily in preclinical research to develop innovative drugs and biologics, fueling demand for sophisticated animal models that can provide reliable efficacy and safety data. The growing focus on vaccine development, particularly in light of emerging infectious diseases and global health threats, is further boosting the market. Additionally, the rising use of animal models in veterinary research to improve livestock productivity and companion animal health is contributing to market expansion. With continuous advancements in genetic engineering and molecular biology, the animal model market is poised for sustained growth, offering new opportunities for research institutions and industry stakeholders worldwide.

SCOPE OF STUDY:

The report analyzes the Animal Model market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Mice, Rat, Guinea Pig, Hamster, Other Animal Types); Application (Cancer Application, Infectious Disease Application, Immunological disease Application, Other Applications); End-Use (Pharma and Biotech Companies End-Use, Contract Research Organizations End-Use, Academic Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Biocytogen Boston Corp.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• Cyagen US Inc.
• Genoway S.A.
• Hera Biolabs
• InnoSer Belgie NV
• Inotiv, Inc.
• Janvier Labs
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• The Jackson Laboratory

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Animal Model - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Preclinical Research in Drug Development Drives the Growth of Animal Model Usage
  • Technological Advancements in Genetic Engineering Enhance the Precision and Reliability of Animal Models
  • Increasing Regulatory Requirements for Drug Safety and Efficacy Strengthen the Business Case for Animal Models
  • Expansion of Biopharmaceutical and Biotechnology Industries Spurs Demand for Advanced Animal Model Testing
  • Growing Emphasis on Personalized Medicine Fuels Demand for Genetically Modified and Humanized Animal Models
  • Rising Prevalence of Chronic Diseases Encourages the Use of Animal Models in Biomedical Research
  • Ethical Concerns and Alternative Testing Methods Present Challenges and Opportunities for Market Innovation
  • Collaborations Between Academic Institutions and Pharmaceutical Companies Drive New Developments in Animal Model Research
  • Increasing Government and Private Funding for Life Sciences Research Boosts Market Growth for Animal Models
  • Emergence of Alternative 3D Culture Systems and In-Vitro Models Pose Competitive Challenges for Animal Testing
  • Expansion of Cancer Research and Oncology Studies Strengthens Demand for Rodent-Based Animal Models
  • Rising Use of Large Animal Models in Regenerative Medicine Research Enhances Market Potential
  • Technological Innovations in Imaging and Monitoring Systems Improve the Efficiency of Animal Model Studies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Animal Model Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Mice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Rat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Guinea Pig by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hamster by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Immunological disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION